Lasa Supergenerics
9.24
+0.05(+0.54%)
Market Cap₹46.00 Cr
PE Ratio13.03
IndustryHealthcare
Company Performance:
1D+0.54%
1M-15.69%
6M-58.27%
1Y-66.49%
5Y-84.26%
View Company Insightsright
Latest news about Lasa Supergenerics
LASA Supergenerics Bolsters Board with Four New Independent Directors Aug 05, 2025
Lasa Supergenerics Limited has appointed four new Additional Directors as Non-Executive Independent Directors for a five-year term starting August 05, 2025. The new directors are Mr. Ketan Bhau Songal (Agro-Veterinary Sciences expert), Mr. Pravin Gadalya Lachake (Poultry operations specialist), Mr. Yogesh Hari Ughada (Animal care professional), and Mrs. Rekha Hemant Wakh (Animal Nutrition specialist). These appointments aim to enhance the company's leadership and bring diverse expertise in veterinary sciences, poultry operations, animal care, and nutrition to its governance structure. The appointments are subject to shareholder approval and comply with SEBI regulations.